Physician profile
Susan E Edmonds
NPI 1811944085
$2,629.67
in general payments reported to CMS, 2019-2025
18 companies · $565 in 2025
The $565 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2021: $122 · 2022: $448 · 2023: $501 · 2024: $689 · 2025: $565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,754.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $362.07 | 2022-2024 | Infuse |
| Alcon Vision LLC | $308.54 | 2019-2025 | Clareon Panoptix Pro, Precision7 |
| Lkc Technologies, INC. | $299.37 | 2024-2025 | |
| Glaukos Corporation | $188.30 | 2023 | |
| Amgen INC. | $153.77 | 2024 | Tepezza |
| Biotissue Holdings INC. | $143.08 | 2024 | |
| Oyster Point Pharma, INC. | $138.01 | 2022-2023 | Tyrvaya |
| Johnson & Johnson Vision Care, INC. | $134.75 | 2019-2023 | Acuvue |
| Dompe US, INC. | $132.43 | 2025 | Oxervate |
| Sight Sciences, INC. | $127.38 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.45 | 2019 | |
| Allergan, INC. | $120.00 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $93.48 | 2024 | Xdemvy |
| Horizon Therapeutics Plc | $75.92 | 2021 | |
| Coopervision INC. | $74.75 | 2025 | Myday Contact Lens |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $62.78 | 2023 | Vuity |
| Shire North American Group INC | $46.95 | 2019 | |
| Visioneering Technologies, INC. | $42.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Edmonds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.